Acquisition by Peter Boyd of 43125 shares of Aquestive Therapeutics at 5.68 subject to Rule 16b-3
| AQ Stock | SEK 136.46 0.36 0.26% |
Slightly above 62% of AQ Group's investor base is looking to short. The analysis of current outlook of investing in AQ Group AB suggests that many traders are alarmed regarding AQ Group's prospects. AQ Group's investing sentiment can be driven by a variety of factors including economic data, AQ Group's earnings reports, geopolitical events, and overall market trends.
AQ Group |
Filed transaction by Aquestive Therapeutics Officer See Remark. Grant, award or other acquisition pursuant to Rule 16b-3
Read at macroaxis.com
AQ Group Fundamental Analysis
We analyze AQ Group's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of AQ Group using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of AQ Group based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
EBITDA
EBITDA Comparative Analysis
AQ Group is currently under evaluation in ebitda category among its peers. EBITDA stands for earnings before interest, taxes, depreciation, and amortization. It is a measure of a company operating cash flow based on data from the company income statement and is a very good way to compare companies within industries or across different sectors. However, unlike Operating Cash Flow, EBITDA does not include the effects of changes in working capital.
AQ Group AB Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with AQ Group stock to make a market-neutral strategy. Peer analysis of AQ Group could also be used in its relative valuation, which is a method of valuing AQ Group by comparing valuation metrics with similar companies.
Peers
AQ Group Related Equities
| ADDT-B | Addtech AB | 1.69 | ||||
| BUFAB | Bufab Holding | 1.40 | ||||
| INWI | Inwido AB | 1.36 | ||||
| BEIA-B | Beijer Alma | 1.04 | ||||
| INDT | Indutrade | 0.56 |
Additional Tools for AQ Group Stock Analysis
When running AQ Group's price analysis, check to measure AQ Group's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy AQ Group is operating at the current time. Most of AQ Group's value examination focuses on studying past and present price action to predict the probability of AQ Group's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move AQ Group's price. Additionally, you may evaluate how the addition of AQ Group to your portfolios can decrease your overall portfolio volatility.